The total issue size of Gensol Engineering IPO is up to ₹17.02 Cr whereas the issue size of the Par Drugs IPO is up to ₹8.10 Cr. The final issue price of Gensol Engineering IPO is ₹83.00 per share and of Par Drugs IPO is ₹51.00 per share.
Gensol Engineering IPO opens on Sep 30, 2019, while Par Drugs IPO opens on May 03, 2019. The closing date of Gensol Engineering IPO and Par Drugs IPO is Oct 04, 2019, and May 08, 2019, respectively.
In the Gensol Engineering IPO Retail Individual Investors (RII) are offered 10,25,600 shares while in Par Drugs IPO retail investors are offered 10,25,600 shares. Qualified Institutional Buyers (QIB) are offered in Gensol Engineering IPO and in Par Drugs IPO.
